Hadassah

Innovative Treatment at Hadassah Preserves Young Patient’s Heart Without Trauma of Open-Heart Surgery

Tuesday, Mar 19 2013

Thanks to a catheterization method of valve replacement, a 15-year-old girl's life was preserved without the need for open-heart surgery.

The adolescent, who suffers from congestive heart failure, needed to have open-heart surgery every few years to replace a valve that was implanted in her body. When she came to Hadassah for her fourth open-heart surgery, Pediatric Cardiologist Dr. Gavri Sagui suggested that this time, she have a newly renovated valve inserted and sutured through an innovative catheterization procedure. The treatment proved successful and now the young girl will not have to undergo any additional open-heart surgeries. She will just need to have the valve replaced again in 10 years, using the same minimally invasive procedure.

"The physical and mental traumas following each surgery were very difficult," the girl's mother said. "This time there was no trauma at all, and she even wrote a book of optimistic poems about her experience."

Dr. Sagui explains that the new procedure enables the patient to go back home within a few days. "The only thing that is left," he says, "is a small incision in the foot."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Aug 13 2019

Alzheimer’s Further Illuminated at Hadassah with New Exclusive Imaging Agent

The Hadassah Medical Organization, through its subsidiary SRY, has contracted to be the sole Israeli agent for General Electric to produce Vizamy, the company’s new radioactive imaging agent to detect, at an early stage, amyloid plaque, which has been linked to the development of Alzheimer’s disease.

READ MORE ›
alt_text

Friday, Aug 2 2019

New Thyroid Eye Disease Clinic at Hadassah Brings Integrated Care to New Mom

Miriam, 34, had just given birth to her third child, and, unlike the joy she felt after her first two births, she felt awful.

READ MORE ›
alt_text

Friday, Aug 2 2019

Eloxx Pharmaceuticals Announces New Drug Application for Clinical Trial in Cystic Fibrosis Patients

Professor Eitan Kerem, head of the Division of Pediatrics at the Hadassah Medical Organization, will serve as the Global Lead Investigator for this clinical trial.

READ MORE ›
alt_text

Wednesday, Jul 31 2019

Skin Cancer Treatment Enhanced in New Center for Dermatologic Surgery

Thanks to a donation by the Israeli businessman and philanthropist Morris Kahn, a major supporter of the Israeli moon spacecraft “Beresheet,” Hadassah Hospital Ein Kerem has just opened the new Center for Dermatologic Surgery, which offers Mohs surgery for patients with common types of skin cancer.

READ MORE ›
SUPPORT HADASSAH HOSPITALS

Learn more about the Hadassah Medical Organization.

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More